by The Kopi Notes | Nov 14, 2026 | Investing
Investing Guide How to Invest in Singapore: Dollar-Cost Averaging vs Lump Sum — Which Strategy Wins? (2026) Dollar-cost averaging (DCA) and lump sum investing are the two core approaches to deploying capital in Singapore. Research from Vanguard shows lump sum...
by The Kopi Notes | Nov 13, 2026 | ETFs
CSPX vs IWDA: S&P 500 or MSCI World for Singapore Investors? (2026) Both are Ireland-domiciled, LSE-listed UCITS ETFs with the same tax treatment — the real choice is concentration vs diversification. CSPX tracks the S&P 500 (100% US large caps, TER 0.07%)...
by The Kopi Notes | Nov 12, 2026 | ETFs
S&P 500 ETF Sell-Off: Should Singapore Investors Buy the Dip With CSPX? (November 2026) The S&P 500 just had its worst day since April 2025. Here’s what actually happened, what it means for CSPX holders, and how a Singapore investor might think about...
by The Kopi Notes | Nov 12, 2026 | Investing
How to Invest in Singapore Tax-Efficiently: SRS, CPF-IS and LSE ETF Strategies (2026) A comprehensive guide to the three tax shelters every Singapore investor should know — updated for 2026. Singapore investors can keep more of their returns through three proven tax...
by The Kopi Notes | Nov 11, 2026 | S REITS
ParkwayLife REIT Complete Investor Guide 2026 (SGX: C2PU): Healthcare REIT with 19-Year Dividend Streak Singapore’s largest listed healthcare REIT — 19 consecutive years of DPU growth, hospital-anchored Singapore assets, and 54+ Japan nursing homes delivering...
by The Kopi Notes | Nov 11, 2026 | S REITS
Mapletree Pan Asia Commercial Trust (MPACT) 2026: Complete Investor Guide — N2IU DPU, Yield & Portfolio SGX: N2IU | Sponsor: Mapletree Investments (Temasek) | Commercial & Retail REIT Mapletree Pan Asia Commercial Trust (MPACT), formerly Mapletree Commercial...